Navigation Links
Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
Date:5/24/2013

he close of business on 22 May 2013, being the last practicable date prior to this announcement, BofA Merrill Lynch and persons controlling, controlled by or under the same control as BofA Merrill Lynch (except in any such case, in the capacity of an exempt market marker, and excluding any exempt fund manager) were interested in 439,332 Elan ADSs and 749,900 derivatives referenced to Elan ADSs.

As at the close of business on 22 May 2013, being the last practicable date prior to this announcement, BofA Merrill Lynch and persons controlling, controlled by or under the same control as BofA Merrill Lynch (except in any such case, in the capacity of an exempt market marker, and excluding any exempt fund manager) held short positions in 759,312 Elan ADSs.

As at the close of business on 22 May 2013, being the last practicable date prior to this announcement, Locus Global I, LP, an entity controlled by Rory Riggs , a director of RP Management (Ireland) Limited was interested in 772 Elan ADSs.

Save as disclosed above, as at the close of business on 22 May 2013, being the last practicable date prior to this announcement, none of Royalty Pharma, RP Management or any person acting in concert with Royalty Pharma or RP Management had any interest, or held any short position, in any relevant securities of Elan.

About Royalty Pharma

RP Management is the investment manager to entities investing in royalty interests in marketed and late stage biopharmaceutical products, with a portfolio of royalty interests in 38 approved and marketed products (including Abbott's Humira®, Johnson and Johnson's Remicade®, Merck's Januvia®, Gilead's Atripla®, Truvada®, and Emtriva®, Pfizer's Lyrica®, Amgen's Neupogen® and Neulasta®, and Genentech's Rituxan®) and two products pending approval. Such product portfolio is well-diversified across biopharmaceutical prod
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
2. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
3. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
4. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
5. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
6. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
7. Royalty Pharma Announces Proposal To Acquire Elan
8. Royalty Rates Take Center Stage in Biopharma Dealmaking
9. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
10. Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
11. Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Aug. 26, 2014  When it comes to diabetes supplies, ... relevance. But Timesulin happens to answer a real medical ... pen on the market, Timesulin shows how long it,s ... preventing from missed or double insulin doses. Very easy ... back on the insulin pen after an injection. There ...
(Date:8/26/2014)... 2014  Ethicon* is introducing three new endocutter and ... of bariatric procedures such as sleeve gastrectomy and gastric ... the 19th World Congress of International Federation for the ... Ethicon is featuring the new ECHELON FLEX ™ ... G2 Articulating Tissue Sealer alongside the HARMONIC ACE ® ...
(Date:8/26/2014)... , Aug. 26, 2014  Avanir Pharmaceuticals, Inc. ... enrollment of the first patient into a phase ... tolerability of AVP-786 for the adjunctive treatment of ... investigational drug consisting of a combination of deuterium ... "There are millions of people with MDD who ...
Breaking Medicine Technology:Montméd obtains reimbursement of Timesulin, the smart insulin pen timer cap, by major insurance companies in Canada 2Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 2Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 3Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 4Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 5Ethicon Expands Bariatric Surgery Portfolio; Unveils "Evidence Corner" At IFSO To Address Obesity And Metabolic Diseases 6Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 6
... Nov. 10, 2011 Shands Jacksonville Medical ... Masimo (NASDAQ: MASI ) ... Center to Masimo rainbow® SET Pulse CO-Oximetry™ technology for ... acute care hospital, which also operates one of the ...
... 2011 Cancer Support Community in collaboration with Center ... to host a workshop from the popular Frankly ... workshop will address the topic of breast reconstruction options, ... MD, and a panel of breast cancer survivors. The ...
Cached Medicine Technology:Shands Jacksonville Medical Center Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 2Shands Jacksonville Medical Center Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 3Shands Jacksonville Medical Center Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 4Shands Jacksonville Medical Center Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 5Shands Jacksonville Medical Center Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 6Cancer Support Community in Collaboration with the Center for Breast Health at Washington Hospital Center Hosts Free Frankly Speaking About Cancer: Spotlight on Breast Reconstruction Workshop on Thursday, November 10 2Cancer Support Community in Collaboration with the Center for Breast Health at Washington Hospital Center Hosts Free Frankly Speaking About Cancer: Spotlight on Breast Reconstruction Workshop on Thursday, November 10 3
(Date:8/27/2014)... Neil Haley, the Total Tutor host of the Simply ... about the importance of capacity to grow a business. , ... and is now a 5 Star Ambassador, Vi Millionaire, and ... titled "The Playful and Powerful Warrior Within You!" and holds ... out for over 1000 days straight. He is also ...
(Date:8/27/2014)... 27, 2014 Overcoming a turbulent past which ... his niche. The Women’s Radio Network, WRNW1, has recently signed ... support and dedication to the WRNW1 family. KC states, “it ... such a positive atmosphere.” After KC Armstrong publicly announced his ... the Howard Stern show, “Howard 100 News,” have decided to ...
(Date:8/27/2014)... A recently published study ... time in correcting coagulopathy to prevent permanent injury or ... anticoagulants and examines medical conditions alleged to be caused ... anticoagulants have been approved by the FDA to reduce ... also known to affect the consistency of the anticoagulation ...
(Date:8/27/2014)... August 27, 2014 The use of ... of life and may eliminate the need for blood ... a recent AllMed webinar, Dr. Zanhua Yi, board certified ... to determining medical necessity of erythropoiesis-stimulating agents (ESAs) in ... , The U.S. Food and Drug Administration (FDA) has ...
(Date:8/27/2014)... Frederick, MD (PRWEB) August 27, 2014 ... and family-friendly practices as the “Most Creative Workplace” ... Frederick County Best Places to Work Awards. , ... the annual event is a joint partnership between ... Department of Economic Development, Frederick County Business Development ...
Breaking Medicine News(10 mins):Health News:Vi Millioniare GJ Reynolds Discusses The Importance of Capacity to Grow a Business on the Simply G Radio Show, a Division of the Simply G Media Network 2Health News:Vi Millioniare GJ Reynolds Discusses The Importance of Capacity to Grow a Business on the Simply G Radio Show, a Division of the Simply G Media Network 3Health News:The Women's Radio Network, WRNW1, Signs KC Armstrong to a Multi-Million Dollar Contract 2Health News:Flood Law Group Comments on Recent AAICH Study 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 3Health News:iHire Named Most Creative Workplace in Frederick, MD 2
... tall extremes may put added pressure on joints, study ... Common genetic variants associated with osteoarthritis may also play ... a U.S.-European study. , The findings, which included an ... are exciting for a number of reasons, said ...
... Childrens Hospital has been named the national lead ... the German-manufactured pediatric heart pump called Berlin Heart ... Fraser, Jr., MD, chief of pediatric and congenital ... E. DeBakey Department of Surgery at Baylor College ...
... transplanted because of the generosity of,donors and their families, ... Perkiomenville, 2007 was a year that brought the greatest ... for a multi-organ,transplant, her parents Shane and Jill watched ... a miracle., That wish was answered just three ...
... today that the United States Food and,Drug Administration ... first LDL cholesterol lowering medication also indicated for,improving ... mellitus (DM) in,combination with metformin, sulfonylureas, or insulin, ... with other anti-diabetic agents., The ADA estimates ...
... Joined by New York City Mayor,Michael Bloomberg, Lance ... today discussed Lance,s request to the Surgeons General,Collective ... "This year alone, 1.4 million Americans are ... likely lose their lives to the disease," said,Lance ...
... the San Diego Supercomputer Center and other parts of ... in Parkinsons Disease, fusion energy and climate change - ... Energy (DOE) as part of its 2008 Innovative and ... , In total, the DOEs Office of Science awarded ...
Cached Medicine News:Health News:Genes Linked to Height Also Tied to Osteoarthritis Risk 2Health News:National study will look at German-made heart pump for children needing heart transplants 2Health News:National study will look at German-made heart pump for children needing heart transplants 3Health News:Gift of Life Celebrates Saving Lives and Setting Records in 2007 2Health News:Gift of Life Celebrates Saving Lives and Setting Records in 2007 3Health News:MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 3Health News:DOE awards supercomputing time to UCSD, SDSC researchers 2Health News:DOE awards supercomputing time to UCSD, SDSC researchers 3
... AIA-1800 is the newest and most advanced ... The AIA-1800 launches with a full menu ... thyroid, reproductive, cardiac, and anemia assays. ,The ... bar-coded primary tube sampling, auto dilution, auto ...
... Tosoh, innovators of automated random access immunoassay testing, ... builds on the proven reliability of Tosohs original ... rapid result processing, and continuous process operation., Test ... T4 FT3 FT4 T-Uptake ...
The FastPack system is a state of the art, lab quality immunoassay system designed for rapid results. The FastPack system delivers lab-quality sensitivity at a fraction of the cost of laboratory....
... Vitros ECi brings true automation and ... testing. Highly sensitive assays for thyroid, ... bone metabolism testing are currently available, ... The Vitros ECi can simultaneously process ...
Medicine Products: